BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10428933)

  • 41. In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis.
    Mouton JW; Endtz HP; den Hollander JG; van den Braak N; Verbrugh HA
    J Antimicrob Chemother; 1997 May; 39 Suppl A():75-80. PubMed ID: 9511068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity of diclazuril against Toxoplasma gondii in cultured cells and mice.
    Lindsay DS; Blagburn BL
    Am J Vet Res; 1994 Apr; 55(4):530-3. PubMed ID: 8017699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ketolide ABT-773 is active against Toxoplasma gondii.
    Khan AA; Araujo FG; Craft JC; Remington JS
    J Antimicrob Chemother; 2000 Sep; 46(3):489-92. PubMed ID: 10980181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil.
    Alves CF; Vitor RW
    Parasite; 2005 Jun; 12(2):171-7. PubMed ID: 15991831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [In vitro activities of quinupristin/dalfopristin in combination with vancomycin and gatifloxacin against Staphylococcus aureus and Enterococcus faecium clinical isolates].
    Gülden E; Ermertcan S
    Mikrobiyol Bul; 2009 Jan; 43(1):53-60. PubMed ID: 19334380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
    Tünger A; Aydemir S; Uluer S; Cilli F
    Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
    Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
    J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High rate of resistance to quinupristin-dalfopristin in Enterococcus faecium clinical isolates from Korea.
    Oh WS; Ko KS; Song JH; Lee MY; Park S; Peck KR; Lee NY; Kim CK; Lee H; Kim SW; Chang HH; Kim YS; Jung SI; Son JS; Yeom JS; Ki HK; Woo GJ
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5176-8. PubMed ID: 16304198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.
    Fagon J; Patrick H; Haas DW; Torres A; Gibert C; Cheadle WG; Falcone RE; Anholm JD; Paganin F; Fabian TC; Lilienthal F
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):753-62. PubMed ID: 10712318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [In vitro effect of combined traditional Chinese medicine (Changqing capsule) on the tachyzoites of Toxoplasma gondii].
    Zhang W; Fang FR; Liu YJ; Yang LD; Luo RY; Gong F; Lu H; Xu XX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):56-8. PubMed ID: 16866146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
    Sambatakou H; Giamarellos-Bourboulis EJ; Grecka P; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Provisional quality control parameters and interpretive criteria for testing susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to quinupristin/dalfopristin (RP59500). Antimicrobial Testing Quality Control Group.
    Fuchs P; Barry A; Brown S
    Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):197-201. PubMed ID: 9665303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.
    Williams JD; Maskell JP; Whiley AC; Sefton AM
    J Antimicrob Chemother; 1997 May; 39 Suppl A():41-6. PubMed ID: 9511061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
    Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
    J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae.
    Jorgensen JH; McElmeel ML
    J Antimicrob Chemother; 1997 May; 39 Suppl A():69-73. PubMed ID: 9511067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toxoplasma gondii: in vivo and in vitro studies of a mutant resistant to arprinocid-N-oxide.
    Pfefferkorn ER; Eckel ME; McAdams E
    Exp Parasitol; 1988 Apr; 65(2):282-9. PubMed ID: 3350108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.
    Bozdogan B; Leclercq R
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2720-5. PubMed ID: 10543753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species.
    Cormican MG; Johnson DM; Jones RN
    Diagn Microbiol Infect Dis; 1996 Jan; 24(1):59-60. PubMed ID: 8988766
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae.
    Izumikawa K; Hirakata Y; Yamaguchi T; Yoshida R; Tanaka H; Takemura H; Maesaki S; Tomono K; Kaku M; Izumikawa KI; Kamihira S; Kohno S
    Antimicrob Agents Chemother; 1998 Mar; 42(3):698-9. PubMed ID: 9517955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.